康恩貝(600572.SH)董事會同意設立公司大健康事業部
格隆匯3月19日丨康恩貝(600572.SH)公佈,公司第九屆董事會2020年第二次臨時會議召開,審議通過《關於設立公司大健康事業部的議案》。
根據公司進一步發展以現代中藥、植物藥為基礎的大健康業務戰略,抓住機遇,更好的規劃、佈局、開拓和管理大健康產品業務,同意設立公司大健康事業部。
大健康事業部主要職責:研究、制定公司大健康產業的發展戰略、發展規劃與實施方案;組織開展和推進公司大健康產業相應的組織架構、業務分工和授權經營體系的建設與協同;組織開展和管理公司大健康產品和外部平台資源的戰略與業務合作;負責收集、整理,分析國內、國際大健康產業發展的信息,為公司決策和業務發展提供支持;組織制定公司大健康事業部和具體業務的管理制度和規則,管理和監督檢查制度規則的實施和業務開展情況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.